Cargando…
Targeting triple-negative breast cancer cells with a β1-integrin binding aptamer
Targeted therapies have increased the treatment options for triple-negative breast cancer patients. However, the paucity of targetable biomarkers and tumor heterogeneity have limited the ability of precision-guided interventions to live up to their full potential. As affinity-targeting ligands, apta...
Autores principales: | Pleiko, Karlis, Haugas, Maarja, Parfejevs, Vadims, Pantelejevs, Teodors, Parisini, Emilio, Teesalu, Tambet, Riekstina, Una |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481362/ https://www.ncbi.nlm.nih.gov/pubmed/37680989 http://dx.doi.org/10.1016/j.omtn.2023.08.015 |
Ejemplares similares
-
Differential binding cell-SELEX method to identify cell-specific aptamers using high-throughput sequencing
por: Pleiko, Karlis, et al.
Publicado: (2019) -
In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues
por: Pleiko, Karlis, et al.
Publicado: (2021) -
Schwann Cells in Digestive System Disorders
por: Goluba, Karina, et al.
Publicado: (2022) -
Divergent binding mode for a protozoan BRC repeat to RAD51
por: Pantelejevs, Teodors, et al.
Publicado: (2022) -
Adult Stem Cell-Derived Extracellular Vesicles in Cancer Treatment: Opportunities and Challenges
por: Parfejevs, Vadims, et al.
Publicado: (2020)